nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A mixed‐methods study to evaluate a patient‐designed tool to reduce harm from cancer‐associated thrombosis: The EMPOWER study
|
Baddeley, Elin |
|
|
5 |
5 |
p. |
artikel |
2 |
A tail of two ITAMs: GPVI/FcRγ and FcγRIIa's role in platelet activation and thrombus stability
|
Neeves, Keith B. |
|
|
5 |
5 |
p. |
artikel |
3 |
Coagulation markers and functional outcome in acute ischemic stroke: Impact of intensive versus standard hyperglycemia control
|
Gentile, Nina T. |
|
|
5 |
5 |
p. |
artikel |
4 |
D‐dimer, thrombin generation, and risk of a first venous thrombosis in the elderly
|
Wang, Huijie |
|
|
5 |
5 |
p. |
artikel |
5 |
Design strategy of antidote sequence for bivalent aptamer: Rapid neutralization of high‐anticoagulant thrombin‐binding bivalent DNA aptamer‐linked M08 with HD22
|
Yoshitomi, Toru |
|
|
5 |
5 |
p. |
artikel |
6 |
Emicizumab initiation and bleeding outcomes in people with hemophilia A with and without inhibitors: A single‐center report
|
Warren, Beth Boulden |
|
|
5 |
5 |
p. |
artikel |
7 |
ERRATUM
|
|
|
|
5 |
5 |
p. |
artikel |
8 |
ERRATUM
|
|
|
|
5 |
5 |
p. |
artikel |
9 |
ERRATUM
|
|
|
|
5 |
5 |
p. |
artikel |
10 |
Fibronectin binding to von Willebrand factor occurs via the A1 domain
|
Keesler, Daniel A. |
|
|
5 |
5 |
p. |
artikel |
11 |
Global reporting of pulmonary embolism–related deaths in the World Health Organization mortality database: Vital registration data from 123 countries
|
Barco, Stefano |
|
|
5 |
5 |
p. |
artikel |
12 |
Health‐related quality‐of‐life questionnaires for deep vein thrombosis and pulmonary embolism: A systematic review on questionnaire development and methodology
|
Asady, Elia |
|
|
5 |
5 |
p. |
artikel |
13 |
Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
|
Kelly, Julie |
|
|
5 |
5 |
p. |
artikel |
14 |
Illustrated State‐of‐the‐Art Capsules of the ISTH 2021 Congress
|
Krishnaswamy, Sriram |
|
|
5 |
5 |
p. |
artikel |
15 |
Impact of an institutional grant award on early career investigator applicants and peer reviewers
|
Mughal, Amreen |
|
|
5 |
5 |
p. |
artikel |
16 |
Improving preprocedure antithrombotic management: Implementation and sustainment of a best practice alert and pharmacist referral process
|
Han, Henry |
|
|
5 |
5 |
p. |
artikel |
17 |
In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity
|
Sim, Derek S. |
|
|
5 |
5 |
p. |
artikel |
18 |
Issue Information
|
|
|
|
5 |
5 |
p. |
artikel |
19 |
Journal impact factor: Recent evaluation changes and Research and Practice in Thrombosis and Haemostasis
|
Coughlin, Brian |
|
|
5 |
5 |
p. |
artikel |
20 |
Living with a “hemophilia‐free mind” – The new ambition of hemophilia care?
|
Krumb, Evelien |
|
|
5 |
5 |
p. |
artikel |
21 |
Low‐dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitors
|
Li, Zekun |
|
|
5 |
5 |
p. |
artikel |
22 |
Menstruation, anticoagulation, and contraception: VTE and uterine bleeding
|
Samuelson Bannow, Bethany |
|
|
5 |
5 |
p. |
artikel |
23 |
Monocyte activation and acquired autoimmune protein S deficiency promote disseminated intravascular coagulation in a patient with primary antiphospholipid syndrome
|
Beckmann, Lennart |
|
|
5 |
5 |
p. |
artikel |
24 |
Musculoskeletal ultrasound in hemophilia: Results and recommendations from a global survey and consensus meeting
|
Bakeer, Nihal |
|
|
5 |
5 |
p. |
artikel |
25 |
Physical forces regulating hemostasis and thrombosis: Vessels, cells, and molecules in illustrated review
|
Lin, Jessica |
|
|
5 |
5 |
p. |
artikel |
26 |
Plasma‐derived factor X concentrate compassionate use for hereditary factor X deficiency: Long‐term safety and efficacy in a retrospective data‐collection study
|
Huang, James N. |
|
|
5 |
5 |
p. |
artikel |
27 |
Post‐discharge thrombosis and bleeding in medical patients: A novel risk score derived from ubiquitous biomarkers
|
Woller, Scott C. |
|
|
5 |
5 |
p. |
artikel |
28 |
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin
|
Bavalia, Roisin |
|
|
5 |
5 |
p. |
artikel |
29 |
Respective roles of Glycoprotein VI and FcγRIIA in the regulation of αIIbβ3‐mediated platelet activation to fibrinogen, thrombus buildup, and stability
|
Ahmed, Muhammad Usman |
|
|
5 |
5 |
p. |
artikel |
30 |
Rivaroxaban thromboprophylaxis for gastric/gastroesophageal junction tumors versus other tumors: A post hoc analysis of the randomized CASSINI trial
|
Mones, Jodi V. |
|
|
5 |
5 |
p. |
artikel |
31 |
Safety of idarucizumab in the reversal of dabigatran at six tertiary care Ontario hospitals
|
Abdulrehman, Jameel |
|
|
5 |
5 |
p. |
artikel |
32 |
The effect of emicizumab and bypassing agents in patients with hemophilia – An in vitro study
|
Schultz, Nina Haagenrud |
|
|
5 |
5 |
p. |
artikel |
33 |
Thrombotic potential during pediatric acute lymphoblastic leukemia induction: Role of cell‐free DNA
|
Kumar, Rahul |
|
|
5 |
5 |
p. |
artikel |
34 |
Tranexamic acid evidence and controversies: An illustrated review
|
Relke, Nicole |
|
|
5 |
5 |
p. |
artikel |
35 |
Use of rotational thromboelastometry to predict hemostatic complications in pediatric patients undergoing extracorporeal membrane oxygenation: A retrospective cohort study
|
Drop, Joppe G. |
|
|
5 |
5 |
p. |
artikel |
36 |
Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
|
Makris, Michael |
|
|
5 |
5 |
p. |
artikel |
37 |
Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
|
Spyropoulos, Alex C. |
|
|
5 |
5 |
p. |
artikel |